We’re launching Lyria 3.5 in Google Flow Music, with advances across musicality, lyrics, vocals, and creative control
deepmind.google·6d ago
AI Engineering
Hacker News·Jun 15·5 min read
The hallucinogenic mushroom that contains no known psychedelic
TL;DR
A gap exists in understanding the cause of vivid hallucinations linked to the consumption of a mushroom called Lanmaoa asiatica. Researchers have sequenced its genome to explore its unique psychoactive properties, which do not align with known psychedelics.
✦ Why It Matters
Engineers and researchers can explore novel psychoactive compounds for therapeutic applications based on this mushroom's unique properties.
Key Takeaways
- Investigate the biochemical properties of Lanmaoa asiatica.
- Explore potential therapeutic applications of unique psychoactive compounds.
- Consider implications for toxicology in edible mushrooms.
- Encourage interdisciplinary research in pharmacology and mycology.
Full Summary
Hallucinogenic effects from the consumption of the mushroom Lanmaoa asiatica, known locally as jian shou qing, have led to numerous hospitalizations due to vivid hallucinations of tiny people, termed Lilliputian hallucinations. Despite its popularity as an edible mushroom, the specific compounds responsible for these effects remain unidentified.
Researchers sequenced the genome of Lanmaoa asiatica to investigate its biochemical properties and potential psychoactive mechanisms. The study revealed that this genus may represent a third family of psychoactive mushrooms, distinct from known categories.
Over 100 cases of hallucinations have been documented annually in a Yunnan hospital, with 96 percent of patients reporting these experiences. The findings suggest a need for further research into the toxicological implications and potential therapeutic applications of these mushrooms.
Understanding this unique chemistry could lead to new insights in both pharmacology and mycology.